Results 91 to 100 of about 1,466,034 (291)
INTENSE PHYSICAL EXERCISE RELATED TO THE EMERGENT GENERATION OF CARDIOVASCULAR RISK MARKERS: A REVIEW [PDF]
, 2012 Objective: The present review was performed in order to bring together the current knowledge about the impact of intense physical exercise on cardiovascular function, especially on plasma levels of cardiovascular risk markers such as cardiac troponin T ...
Caroline Le Goff +3 more
core +1 more source
Advanced Science, EarlyView.This study highlights that radioimmunotherapy drives crosstalk between fibroblasts and immune cells (especially macrophages) in the cardiac microenvironment, with IL‐6 as the key mediator, and tocilizumab alleviates cardiac fibrosis by targeting this interplay.
Yuxi Luo +10 more
wiley +1 more source
Cardiac biomarkers in premature calves with respiratory distress syndrome [PDF]
, 2016 The aim of this study was to determine the clinical relevance of cardiac biomarkers [troponin I and T, creatine kinase-MB fraction (CK-MB) and lactate dehydrogenase (LDH)] in premature calves with respiratory distress syndrome.
Aydogdu, Ugur +4 more
core +1 more source
Real‐Time Digital Micromotor Tracking‐Enabled Ultrasensitive Immunoassay
Advanced Science, EarlyView.An AI‐facilitated real‐time digital micromotor tracking‐enabled immunoassay is developed, which leverages a self‐developed multi‐microparticle tracking system to monitor micromotor motion trajectories in a real‐time manner for digital protein analysis.
Jingjing Shi +6 more
wiley +1 more source
Biomarkers Beyond the Natriuretic Peptides for Chronic Heart Failure: Galectin-3 and Soluble ST2. [PDF]
, 2012 B-type natriuretic peptide (BNP) and NT-proBNP are widely used plasma biomarkers for the diagnosis of acute decompensated heart failure and prognosis for future cardiac disease.
Wu, Alan HB
core +4 more sources
Impact of troponin I on outcome of ischemic stroke patients
Romanian Journal of Internal Medicine, 2017 Introduction. Stroke is one of the leading causes of morbidity and mortality. Cardiac troponins have been found to be increased in other conditions apart from the cardiac diseases, such as stroke.
Budincevic Hrvoje +5 more
doaj +1 more source
Soluble CD40 ligand in acute coronary syndromes [PDF]
, 2003 BACKGROUND: CD40 ligand is expressed on platelets and released from them on activation. We investigated the predictive value of soluble CD40 ligand as a marker for clinical outcome and the therapeutic effect of glycoprotein IIb/IIIa receptor inhibition ...
Boersma, H. (Eric) +6 more
core +1 more source
TRIM40 Drives Pathological Cardiac Hypertrophy and Heart Failure via Ubiquitination of PKN2
Advanced Science, EarlyView.This study identifies the E3 ligase TRIM40 as a key driver of pathological cardiac hypertrophy. TRIM40 binds PKN2 via its B‐box domain and, through its C29‐dependent catalytic activity, mediates K63‐linked ubiquitination of PKN2. This modification enhances PKN2 phosphorylation at Ser815, thereby driving hypertrophy.
Risheng Zhao +12 more
wiley +1 more source
Predictors of significant coronary artery disease in atrial fibrillation: are cardiac troponins a useful measure [PDF]
, 2016 Background Cardiac Troponin I (cTnI) is frequently measured in patients presenting with symptomatic atrial fibrillation (AF). The significance of elevated cTnI levels in this patient cohort is unclear.
Alghamry, Alaa +9 more
core +1 more source
Advanced Science, EarlyView.Doxorubicin (DOX)‐induced cardiotoxicity is a major limitation to its broader clinical application, while cardioprotective interventions often risk reducing the anticancer efficacy of DOX. To address these challenges, this work constructs an EDTA‐functionalized metal–organic framework that enhances tumor therapy and provides efficient cardioprotection ...
Daojing Yuan +8 more
wiley +1 more source